Background: No study has so far compared Amulet with the new Watchman FLX in terms of
residual left atrial appendage (LAA) patency or clinical outcomes in patients undergoing …

Background In this analysis of the EWOLUTION registry, we evaluated the incidence,
relevance and predictors of device‐related thrombus in a large multi‐center real‐world …

Aims Left atrial appendage closure is a non-pharmacological alternative for stroke
prevention in high-risk patients with non-valvular atrial fibrillation. The objective of the …

Aims To evaluate the safety and efficacy of left atrial appendage occlusion (LAAO) with the
Amplatzer™ Amulet™ occluder. Methods and results Patients with atrial fibrillation eligible …

Aims The global, prospective AMPLATZER Amulet observational study documents real-
world periprocedural, transoesophageal echocardiographic (TEE) and clinical outcomes …

Background Left atrial appendage occlusion (LAAO) has been proven to be effective for
stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). We aim to assess …

Background: Left atrial appendage (LAA) occlusion provides an alternative to oral
anticoagulation for thromboembolic risk reduction in patients with nonvalvular atrial …

Abstract Background The Amplatzer™ Amulet™(Amulet) is the evolution of the Amplatzer™
Cardiac Plug, a dedicated device for percutaneous left atrial appendage (LAA) occlusion …

Percutaneous left atrial appendage closure technology for stroke prevention in patients with
atrial fibrillation has significantly advanced in the past 2 decades. Several devices are under …

Percutaneous left atrial appendage (LAA) closure is becoming a frequently performed
procedure for patients with atrial fibrillation and high haemorrhagic risk. The Amplatzer™ …